Originally published by our sister publication Gastroenterology & Endoscopy News
By Chase Doyle
VANCOUVER, B.C.—Therapeutic strategies employing a combination of advanced therapies, specifically dual biologics or biologic–small molecule combinations, are starting to reveal promising outcomes in the treatment of inflammatory bowel disease.
At the 2023 annual meeting of the American College of Gastroenterology, Christopher Ma, MD, MPH, FRCPC, an associate professor of